Prolonged Antidepressant Treatment No Benefit in Bipolar I Disorder

THURSDAY, Aug. 3, 2023 -- For patients with bipolar I disorder who had recently had remission of a depressive episode, adjunctive treatment with escitalopram or bupropion XL that continues for 52 weeks does not show a significant benefit compared...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news